top of page

OUR JOURNEY

To temporarily alter the barrier characteristics of the elastin-collagen matrix to allow large molecule drugs to be absorbed through the skin into the body.  

OUR TEAM

Redefining  
Transdermal Delivery

Our team of experts has extensive experience in product development, drug delivery, pre-clinical and clinical pharmacological research, and pharmaceutical and medical device licensing and marketing. We are committed to providing our patients with the highest quality products and services.

 

Our Board of Directors, senior management, and group of scientific advisors have the expertise and experience to ensure that our products meet the highest standards of safety and efficacy.

Rectangle -22.png

Our Journey So Far

2012

HYPOSPRAY IS FOUNDED

The company was formed as a Florida corporation and registered as a "C" corporation capitalized from revenue generated from a wholly-owned subsidiary.

2013

GROUNDBREAKING TRANSDERMAL TECHNOLOGY RESEARCHED

First approvals for clinical studies received and regulatory compliance instructions executed as directed by US FDA.

Our Team.

At HypoSpray Pharma, we’re committed to providing our clients with safe and effective drug delivery services. Our team has over 20 years of experience in the pharmaceutical industry, and we’re passionate about providing our clients with the highest level of quality care.

Technical Advisory Board.

Our team is composed of industry veterans with decades of experience in product development, pre-clinical and clinical pharmacological research, and pharmaceutical manufacturing. 

Scientific Board

Our team is composed of industry veterans with decades of experience in product development, pre-clinical and clinical pharmacological research, and pharmaceutical manufacturing. 

NEWS

HYPOSPRAY In The Press

bottom of page